Cosmetic Surgery Market Outlook
The Global Cosmetic Surgery industry was worth US$69.93 billion in 2023, and it will grow at a CAGR of 9.95% from 2024 to 2032. By 2032, it will likely be valued at US$164.22 billion.
Cosmetic or plastic surgery involves procedures to enhance or alter a person's appearance. It includes a variety of non-invasive and surgical techniques aimed at helping individuals feel more confident, correcting physical abnormalities or asymmetries, improving the appearance of scars or other skin imperfections, and enhancing their overall physical appearance. The demand for these procedures is fueled by the rise of cosmetic and medical tourism, increased investment in healthcare infrastructure, and the development of high-quality medical facilities.
Request a free sample copy of the report: https://www.renub.com/cosmetic-surgery-market-p.php
One of the primary drivers of the cosmetic surgery market is the growing demand for aesthetic enhancements, fueled by societal pressures and the influence of media and celebrity culture. In today's image-conscious society, individuals of all ages increasingly seek cosmetic procedures to address perceived flaws or imperfections and achieve their desired aesthetic goals. Breast augmentation, liposuction, rhinoplasty, and facelifts are among the most popular surgical options. At the same time, non-surgical treatments like Botox, fillers, and laser hair removal are also in high demand.
Advancements in medical technology and techniques have played a crucial role in the growth of the cosmetic surgery market. They enable safer, more effective, and less invasive procedures with minimal downtime and improved outcomes. Innovations such as minimally invasive surgeries, 3D imaging technology, and robotic-assisted procedures have revolutionized the field, offering patients more options and better results than ever before.
Changing demographics and societal attitudes have also expanded the cosmetic surgery market. With the aging population, there is a growing demand for anti-aging treatments and rejuvenation procedures to maintain a youthful appearance and enhance quality of life. Additionally, men are increasingly turning to cosmetic surgery to address concerns such as hair loss, gynecomastia, and facial aging, reflecting shifting gender norms and attitudes toward male grooming and appearance.
Globalization and medical tourism have further fueled the growth of the cosmetic surgery market, with patients traveling abroad to access high-quality care at lower costs or to seek out specialized procedures and renowned surgeons. Countries like South Korea, Brazil, Mexico, and Thailand have emerged as popular destinations for cosmetic surgery tourism, offering a wide range of procedures and amenities to attract international patients.
Despite its growth, the cosmetic surgery market faces challenges such as regulatory oversight, patient safety concerns, and ethical considerations surrounding body image and self-esteem. However, with increasing demand, technological advancements, and evolving consumer preferences, the market is expected to continue expanding, offering new opportunities for innovation and growth in the years to come.
North America Cosmetic Surgery Market:
North America leads the beauty surgery market due to the region's increasing focus on outward appearance, availability of advanced cosmetic treatments, and technological advancements. Information on aesthetic plastic surgery indicates that non-invasive procedures increased by 44%, while surgical procedures accounted for 54%. In 2021, 365,000 breast augmentations were performed, with women comprising approximately 94% of all patients. Furthermore, 148,000 women underwent implant replacement surgery, surpassing the 71,000 who had their implants removed without replacement. Despite representing only 21% of procedures, surgical operations generate 69% of total revenue.
Europe Beauty Surgery Market:
Due to increasing healthcare costs, skin issues, and technological advancements, the cosmetic surgery market in Europe holds the second-largest market share. For instance, the British Association of Aesthetic Plastic Surgeons (BAAPS) reported nearly 27,000 procedures in 2019, with skin tightening being the most common surgery. Additionally, the cosmetic surgery market in Germany is believed to have the largest share, while the market in France is expected to experience the fastest growth rate in Europe.
Cosmetic Surgery Market Company Overview:
Some of the industry leaders in the Global Cosmetic Surgery Market include AbbVie Inc., Cutera Inc., Siestra Inc., Bauch Health Firms Inc., Johnson Johnson Services, Inc., Apex Medical, Hologic, Merz Pharma, Galderma, and Cynosure.
Cosmetic Surgery Market News:
TILA Bio, Inc. introduced the OviTex PRS Long-Term Resorbable product to the American market in August 2023. This product applies to both reconstructive and plastic surgery.
Establishment Labs Holdings Inc. stated in Walk 2023 that it has signed agreements with four partners in Europe and another chain of partners in Japan to introduce Mia Femtech, a 15-minute process that increases breast shape.
In July 2022, Cutera declared that AviClear, the first and only laser treatment device authorized to treat light, average, and intense acne in the United States, has received permission.
In July 2022, BIOPLUS CO., LTD. declared that China had given a specific import license for its two sorts of hyaluronic acid fillers. Among the items were Skin Plus HYAL Implant and DeneB.
In July 2022, LightStim launched Elipsa, the first LED device to give two treatment options for wrinkles and acne. Users can use this machine at home.
Cynosure's PicoSure Pro machine was released in June 2022. This machine uses an improved platinum lens focus array to increase the amount of collagen and elastin in the skin and decrease pores, wrinkles, and acne scars.
In May 2022, Apyx Medical communicated that the US Food and Drug Management had permitted 510(k) to use its Renuvion Dermal Handpiece for unique dermal resurfacing.
Gender – Market breakup in 2 viewpoints:
- Female
- Male
Age Group – Market breakup in 3 viewpoints:
- 13 to 29
- 30 to 54
- 54 and above
Procedure – Market breakup in 2 viewpoints:
- Surgical Procedure
- Non-Surgical Procedure
End User – Market breakup in 3 viewpoints:
- Ambulatory Surgical Facility
- Hospital and Clinic
- Office and Cosmetic Surgical Center
Country – Market breakup of 25 Countries:
- North America
1.1 United States
1.2 Canada
- Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
- Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
- Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
- Middle East Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 4 Viewpoints:
- Overview
- Recent Development
- Product Portfolio
- Financial Insights
Company Analysis:
- AbbVie Inc.
- Cutera Inc.
- Sientra Inc.
- Bausch Health Companies Inc.
- Johnson Johnson Services, Inc.
- Apyx Medical
- Hologic
- Merz Pharma
- Galderma
- Cynosure
Related Reports:
Global Self-Monitoring Blood Glucose Device Market
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Website: https://www.renub.com/
